Hematology/Oncology

Rotow J, Patel JD, Hanley MP, Yu H, Awad M, Goldman JW, Nechushtan H, Scheffler M, Kuo CS, Rajappa S, Harada G, Clifford S, Santucci ...

By sjmartinez • March 31, 2023

Stefanoudakis D, Kathuria-Prakash N, Sun AW, Abel M, Drolen CE, Ashbaugh C, Zhang S, Hui G, Tabatabaei YA, Zektser Y, Lopez LP, Pantuck A, Drakaki ...

By sjmartinez • March 30, 2023

Daniels-Wells TR, Candelaria PV, Kranz E, Wen J, Wang L, Kamata M, Almagro JC, Martínez-Maza O, Penichet ML. Efficacy of Antibodies Targeting TfR1 in Xenograft ...

By sjmartinez • March 30, 2023

Bahdi F, Alkassis S, Lewis MS, El-Masry M, Bejjani A, Kolb JM. Numerous gastric nodules in a leukaemia patient. Gut. 2023 Mar 29:gutjnl-2023-329699. doi: 10.1136/gutjnl-2023-329699. ...

By sjmartinez • March 30, 2023

Corey JJ, Shirazipour CH, Fricke M, Evans B. Physiotherapists' role in physical activity promotion: Qualitative reflections of patients and providers. Physiother Theory Pract. 2023 Apr;39(4):814-826. ...

By sjmartinez • March 29, 2023

Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon ...

By sjmartinez • March 29, 2023

Epistola R, Sperandio R, Wainberg Z, Iqbal S, Chao J. Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported Outcomes. ...

By sjmartinez • March 28, 2023

LeVee A, Spector K, Larkin B, Dezem F, Plummer J, Dadmanesh F, Patil S, McArthur HL. Incidence and prognostic impact of HER2-positivity loss after dual ...

By sjmartinez • March 28, 2023

Ma TM, Feng FY, Rosenthal SA, Rettig MB, Raldow AC, Spratt DE, Xiang M, Kishan AU. Race-dependent association of clinical trial participation with improved outcomes ...

By sjmartinez • March 26, 2023

McAuley GE, Yiu G, Chang PC, Newby GA, Campo-Fernandez B, Fitz-Gibbon ST, Wu X, Kang SL, Garibay A, Butler J, Christian V, Wong RL, Everette ...

By sjmartinez • March 22, 2023